Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.3283 USD
−2.19 M USD
0.00 USD
1.21 M
About Mydecine Innovations Group, Inc.
Sector
Industry
CEO
David Joshua Bartch
Website
Headquarters
Vancouver
Founded
2013
ISIN
CA62849F4087
FIGI
BBG00864XZL0
Mydecine Innovations Group, Inc. is a biotechnology company, which engages in the research, drug development, and clinical trials of psilocybin products. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MYCOF is 0.0956 USD — it has decreased by −59.53% in the past 24 hours. Watch MYDECINE INNOVATIONS GROUP INC NEW stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange MYDECINE INNOVATIONS GROUP INC NEW stocks are traded under the ticker MYCOF.
MYCOF reached its all-time high on Dec 29, 2017 with the price of 37,125.0000 USD, and its all-time low was 0.0050 USD and was reached on Mar 4, 2024. View more price dynamics on MYCOF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MYCOF stock is 147.07% volatile and has beta coefficient of −8.53. Track MYDECINE INNOVATIONS GROUP INC NEW stock price on the chart and check out the list of the most volatile stocks — is MYDECINE INNOVATIONS GROUP INC NEW there?
Yes, you can track MYDECINE INNOVATIONS GROUP INC NEW financials in yearly and quarterly reports right on TradingView.
MYDECINE INNOVATIONS GROUP INC NEW is going to release the next earnings report on Mar 27, 2026. Keep track of upcoming events with our Earnings Calendar.
MYCOF net income for the last quarter is 52.98 K USD, while the quarter before that showed −9.51 K USD of net income which accounts for 657.19% change. Track more MYDECINE INNOVATIONS GROUP INC NEW financial stats to get the full picture.
No, MYCOF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MYCOF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MYDECINE INNOVATIONS GROUP INC NEW stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MYDECINE INNOVATIONS GROUP INC NEW technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MYDECINE INNOVATIONS GROUP INC NEW stock shows the sell signal. See more of MYDECINE INNOVATIONS GROUP INC NEW technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.